Magnesium amino acid chelate
19
labels across all brands · median 300 mg/serving
Brand · NIH DSLD
Metagenics files 4 on-market magnesium labels; the magnesium salt is not named in the filed record for any of them, so the compound mass cannot be computed.
Composition across the portfolio · as filed
Label declarations · as filed
Filed declarations across this brand's labels: 3 distinct filed entries across 4 NIH DSLD labels, counted 2026-09-13; these are manufacturer statements.
What is not known · as of 2026-09-13
| Bone Builder with MagnesiumNIH DSLD · Label 295642 · Tablet or Pill | form not mapped yet | 300 mg | 30 | 9.00 g | Not tracked yet |
| Bone Builder with MagnesiumNIH DSLD · Label 323336 · Tablet or Pill | form not mapped yet | 300 mg | 60 | 18.00 g | Not tracked yet |
| Cal Apatite with MagnesiumNIH DSLD · Label 26518 · Tablet or Pill | amino acid chelate, aspartate, bis-glycinate, citrate | 300 mg | 30 | 9.00 g | Not tracked yet |
| Cal Apatite with MagnesiumNIH DSLD · Label 26519 · Tablet or Pill | amino acid chelate, aspartate, bis-glycinate, citrate | 300 mg | 60 | 18.00 g | Not tracked yet |
Forms filed
19
labels across all brands · median 300 mg/serving
33
labels across all brands · median 200 mg/serving
118
labels across all brands · median 217.5 mg/serving
65
labels across all brands · median 300 mg/serving
See all brands, all labels, or the priced form tables.
8 published excipient facets occur across 4 labels from Metagenics in the NIH DSLD records, counted 2026-09-13.
The FDA adverse event reporting system (CAERS) holds 24 reports naming Metagenics as of 2026-09-13. This is a count of submitted reports across all the firm's products; it is not an incidence rate and implies no causation.
The metric
EC100 = container price ÷ (elemental mg per serving × servings per container ÷ 100)
It normalizes the declared elemental amount to a 100 mg unit. It does not score ingredients, quality, or outcomes.